Condition: Prostate Cancer (Adenocarcinoma) · Sponsor: Clinique Sainte Clotilde
This study evaluates whether adaptive stereotactic body radiotherapy (SBRT) provides dosimetric advantages compared to non-adaptive SBRT in localized prostate cancer. Five low-dose CT scans are performed before each SBRT session to assess anatomical variations (bladder filling, rectal volume) and determine if a dosimetric recalculation would have been required. The study also evaluates cumulative dose to organs at risk, patient-reported quality of life over 24 months, and overall and recurrence-free survival.
This description comes directly from the study's public registry record.
MANON Leprince, Clinical Research Associate · 0692341365 · manon.leprince@clinifutur.net
Mickael Begue, Principal Investigator · manon.leprince@clinifutur.net
Always discuss trial participation with your own doctor first.
| Clinique Sainte Clotilde | Saint-Denis, Reunion | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07344844